1. |
New directions in drug discovery: targeting RNA |
|
Inpharma Weekly,
Volume &NA;,
Issue 1386,
2003,
Page 2-2
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2003
数据来源: ADIS
|
2. |
Gene vaccines the way of the future? |
|
Inpharma Weekly,
Volume &NA;,
Issue 1386,
2003,
Page 3-3
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2003
数据来源: ADIS
|
3. |
A recent increase in the incidence ofHaemophilus influenzaetype b (Hib) infections in the UK*is unlikely to be due to a random variation in Hib disease, |
|
Inpharma Weekly,
Volume &NA;,
Issue 1386,
2003,
Page 4-4
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2003
数据来源: ADIS
|
4. |
PEG IFN-α-2b + weight-based ribavirin best value in hep C |
|
Inpharma Weekly,
Volume &NA;,
Issue 1386,
2003,
Page 5-5
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2003
数据来源: ADIS
|
5. |
Roxifiban promising in stable coronary artery disease |
|
Inpharma Weekly,
Volume &NA;,
Issue 1386,
2003,
Page 6-6
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2003
数据来源: ADIS
|
6. |
Everolimus: advantages over azathioprine in lung transplantation |
|
Inpharma Weekly,
Volume &NA;,
Issue 1386,
2003,
Page 7-8
RM Poole,
Preview
|
|
摘要:
Interim results from an international phase III study indicate that the novel immunosuppressant everolimus [`Certican'] is more effective than azathioprine in stable lung transplant recipients. One-year data presented at the 23rd Annual Meeting and Scientific Sessions of the International Society for Heart and Lung Transplantation [Vienna, Austria; April 2003] showed that everolimus was more effective than azathioprine in preventing acute rejection and preserving pulmonary function in lung and heart/lung transplant recipients. According to the researchers, this is the first time a drug has significantly reduced the decline in lung function that frequently occurs after lung transplantation.
ISSN:1173-8324
出版商:ADIS
年代:2003
数据来源: ADIS
|
7. |
The intranasal influenza virus vaccine `FluINsure'*appears to be safe and effective, |
|
Inpharma Weekly,
Volume &NA;,
Issue 1386,
2003,
Page 8-8
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2003
数据来源: ADIS
|
8. |
Carmustine polifeprosan 20 wafer prolongs survival in patients with malignant glioma, |
|
Inpharma Weekly,
Volume &NA;,
Issue 1386,
2003,
Page 10-10
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2003
数据来源: ADIS
|
9. |
Donepezil beneficial across the dementia spectrum |
|
Inpharma Weekly,
Volume &NA;,
Issue 1386,
2003,
Page 11-12
RM Poole,
Preview
|
|
摘要:
The acetylcholinesterase inhibitor donepezil [`Aricept'], already established as a treatment for mild-to-moderate Alzheimer's disease, has also demonstrated efficacy in vascular dementia. Now, studies presented at the 55th Annual Meeting of the American Academy of Neurology [Honolulu, US; March−April 2003] indicate that donepezil is also effective in other types of dementia, with significant improvements in memory and/or cognition observed in patients with mild cognitive impairment (MCI), multiple sclerosis (MS) and Parkinson's disease. Furthermore, an analysis of data from patients with severe Alzheimer's disease involved in the Moderate to Severe Alzheimer's Disease (MSAD) study showed that donepezil provided significant functional, cognitive and behavioural benefits in this patient population.
ISSN:1173-8324
出版商:ADIS
年代:2003
数据来源: ADIS
|
10. |
Reduced effectiveness of Hib vaccination in the UK |
|
Inpharma Weekly,
Volume &NA;,
Issue 1386,
2003,
Page 13-13
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2003
数据来源: ADIS
|